PATENT CLAIM ANALYSIS

Application Number: 16164550
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "04400A"]

Abstract:
Embodiments of the disclosure include methods and compositions for the renewal of cardiomyocytes by targeting the Hippo pathway. In particular embodiments, an individual with a need for cardiomyocyte renewal is provided an effective amount of a shRNA molecule that targets the Sav1 gene. Particular shRNA sequences are disclosed.

Claim (Index 32):
The method of  claim 27 , wherein the composition is provided to the individual more than once.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 97.0
- Lexical Diversity: 1.3
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15102593', '15642200', '14333207', '13504614', '12737213']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7829948272209761
- 35 USC 102 Novelty (BERT): 0.6191451910799168
- Combined Prediction Score: 0.7666098636068702
- Mean Citation Score: 413.02238
- Max Citation Score: 631.0655
- Similarity Product: 468.4363684631288

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test